RxDoctor Payments Data

Melissa Pixley, APRN

Family · Kokomo, INNPI 1114318391

Payments from drug & device makers

$391in general payments, 2019–2025

Across 16 payments — averaging $24.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$77
  • Lilly USA, LLC$76
  • Abbott$66
  • Medtronic$28
  • Insulet Corporation$22
  • Amryt Pharma Holdings Ltd$20
  • plus $101 from 7 others

What the payments were for

  • Food & beverage$37997%
  • Education$123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$391 in reported general payments places this provider in the 50th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$5,649
Medicare patients
51
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$42,271
TrulicityDulaglutide14$23,264
JardianceEmpagliflozin26$22,061
MounjaroTirzepatide14$18,271
Tresiba Flextouch U-200Insulin Degludec18$17,291
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$16,149
Humalog Kwikpen U-100Insulin Lispro16$9,536
Nano 2nd Gen Pen NeedlePen Needle, Diabetic12$1,392
Ultra-Fine Short Pen NeedlePen Needle, Diabetic17$1,374
SynthroidLevothyroxine Sodium12$1,030
Levothyroxine Sodium84$698
Rosuvastatin Calcium22$373
Atorvastatin Calcium25$261
Gabapentin24$259
Metformin Hcl18$144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$42,27125 claims
Lilly USA, LLCTrulicity, Mounjaro$76$41,53528 claims
AbbVieSynthroid$18$1,03012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,392 family providers in Indiana.

Other family in Kokomo

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →